Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziad Zakaria

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Oncologist|January 9, 2026
How Often Do Oncologists Receive Industry Payments from Competing Companies?Helen M Keetley, Ziad Zakaria, Grace Gallagher, et al.
Journal of the National Cancer Institute|March 30, 2026
Use of Low-Value Cancer Care in Practices Acquired by Private Equity FirmsAaron P Mitchell, Miranda B Lam, Caroline Carlin, et al.
JCO Oncology Practice|December 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast CancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Journal of the National Cancer Institute|May 20, 2026
Response to Yu, Wang, and GeYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Journal of the National Cancer Institute|March 5, 2026
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Oncologist|January 9, 2026
How Often Do Oncologists Receive Industry Payments from Competing Companies?Helen M Keetley, Ziad Zakaria, Grace Gallagher, et al.
Journal of the National Cancer Institute|March 30, 2026
Use of Low-Value Cancer Care in Practices Acquired by Private Equity FirmsAaron P Mitchell, Miranda B Lam, Caroline Carlin, et al.
JCO Oncology Practice|December 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast CancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Journal of the National Cancer Institute|May 20, 2026
Response to Yu, Wang, and GeYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Journal of the National Cancer Institute|March 5, 2026
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Pageof 1